European Healthcare Expenditure on Prescribed Medicines by Country

In 2024, Malta leads European healthcare expenditure on prescribed medicines as a percentage of GDP at 1.77%, followed closely by Cyprus at 1.67%. Germany also ranks high with 1.52%, whereas Denmark and Luxembourg exhibit the lowest expenditures with values of 0.4% and 0.41%, respectively. Year-on-year variations from 2023 reveal significant fluctuations: Malta (+6.86%), Cyprus (+14.46%), and Iceland (+7.89%) saw considerable increases, whereas Poland (-3.26%) and Latvia (-2.53%) experienced notable decreases. Over the past five years, trends indicate generally stable to moderately increasing expenditures driven by ongoing healthcare investments.

Future trends to watch for include:

  • Impacts of aging populations on healthcare demand across Europe
  • Implementation and effects of new drug policies and pricing regulations
  • Advancements in pharmaceutical technologies and personalized medicine
  • Economic shifts affecting national budgets available for healthcare

Top countries in Healthcare Expenditure on Prescribed Medicines by Country

# 10 Countries Percent of GDP Last Year YoY 5-years CAGR
1 1 Malta 1.77 2023 +2.31% +6.86% View data
2 2 Cyprus 1.67 2023 +10.6% +14.46% View data
3 3 Hungary 1.66 2023 +1.22% -0.24% View data
4 4 Germany 1.52 2023 +0.66% +1.23% View data
5 5 Slovakia 1.35 2023 -1.46% -1.69% View data
6 6 France 1.27 2023 -1.55% -0.62% View data
7 7 Slovenia 1.18 2023 0% +0.69% View data
8 8 Croatia 1.18 2023 +1.72% +3.78% View data
9 9 Spain 1.09 2023 -0.91% +1.34% View data
10 10 Bosnia and Herzegovina 1.06 2023 -0.93% +1.17% View data

Top Countries about Prescription Drug